Reekie Joanne, Donovan Basil, Guy Rebecca, Hocking Jane S, Jorm Louisa, Kaldor John M, Mak Donna B, Preen David, Pearson Sallie, Roberts Christine L, Stewart Louise, Wand Handan, Ward James, Liu Bette
The Kirby Institute, UNSW Australia, Sydney, Australia.
The Kirby Institute, UNSW Australia, Sydney, Australia; Sydney Sexual Health Centre, Sydney Hospital, Sydney, Australia.
PLoS One. 2014 Apr 17;9(4):e94361. doi: 10.1371/journal.pone.0094361. eCollection 2014.
The presence and severity of pelvic inflammatory disease (PID) symptoms are thought to vary by microbiological etiology but there is limited empirical evidence. We sought to estimate and compare the rates of hospitalisation for PID temporally related to diagnoses of gonorrhoea and chlamydia.
All women, aged 15-45 years in the Australian state of New South Wales (NSW), with a diagnosis of chlamydia or gonorrhoea between 01/07/2000 and 31/12/2008 were followed by record linkage for up to one year after their chlamydia or gonorrhoea diagnosis for hospitalisations for PID. Standardised incidence ratios compared the incidence of PID hospitalisations to the age-equivalent NSW population.
A total of 38,193 women had a chlamydia diagnosis, of which 483 were hospitalised for PID; incidence rate (IR) 13.9 per 1000 person-years of follow-up (PYFU) (95%CI 12.6-15.1). In contrast, 1015 had a gonorrhoea diagnosis, of which 45 were hospitalised for PID (IR 50.8 per 1000 PYFU, 95%CI 36.0-65.6). The annual incidence of PID hospitalisation temporally related to a chlamydia or gonorrhoea diagnosis was 27.0 (95%CI 24.4-29.8) and 96.6 (95%CI 64.7-138.8) times greater, respectively, than the age-equivalent NSW female population. Younger age, socio-economic disadvantage, having a diagnosis prior to 2005 and having a prior birth were also associated with being hospitalised for PID.
Chlamydia and gonorrhoea are both associated with large increases in the risk of PID hospitalisation. Our data suggest the risk of PID hospitalisation is much higher for gonorrhoea than chlamydia; however, further research is needed to confirm this finding.
盆腔炎(PID)症状的存在及严重程度被认为因微生物病因不同而有所差异,但实证证据有限。我们试图估计并比较与淋病和衣原体诊断存在时间关联的PID住院率。
对澳大利亚新南威尔士州(NSW)年龄在15至45岁之间、于2000年7月1日至2008年12月31日期间被诊断为衣原体或淋病的所有女性,通过记录链接对其衣原体或淋病诊断后长达一年的PID住院情况进行跟踪。标准化发病率比将PID住院发病率与年龄匹配的新南威尔士州人群进行比较。
共有38193名女性被诊断为衣原体感染,其中483人因PID住院;发病率为每1000人年随访(PYFU)13.9例(95%可信区间12.6 - 15.1)。相比之下,1015人被诊断为淋病,其中45人因PID住院(发病率为每1000 PYFU 50.8例,95%可信区间36.0 - 65.6)。与衣原体或淋病诊断存在时间关联的PID住院年发病率分别比年龄匹配的新南威尔士州女性人群高27.0倍(95%可信区间24.4 - 29.8)和96.6倍(95%可信区间64.7 - 138.8)。年龄较小、社会经济地位不利、在2005年之前被诊断以及有过生育史也与因PID住院有关。
衣原体和淋病均与PID住院风险大幅增加有关。我们的数据表明,淋病导致PID住院的风险远高于衣原体;然而,需要进一步研究来证实这一发现。